Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,262 public trials 443 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Active, Not Recruiting

Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix

NCT07182838

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Medicine Invention Design Incorporation - IORG0007849 - NPI 1023387701 Rockville, Maryland, United States

View Trial Details

Active, Not Recruiting

A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B

NCT07203118

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: The First Hospital of Jilin University Jilin City, changchun, China

View Trial Details

Active, Not Recruiting

Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion

NCT07204236

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Shandong Province Public Health Clinical Center Jinan, Shandong, China

View Trial Details

Active, Not Recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B

NCT07190742

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus, +15 more
Locations: Peking University first hospital Beijing, China

View Trial Details

Active, Not Recruiting

Implementation and Effectiveness of Physical Activity to Prevent Disability in HIV-infected Adults Older Than 50 From Côte d'Ivoire

NCT06139497

Conditions: Behavior, Blood-Borne Infections, Cardiovascular Diseases, +25 more
Locations: Centre Médical Spécialisé El Rapha Abidjan, Côte d’Ivoire

Formation semi urbaine (FSU) d'Abobo Avocatier Abidjan, Côte d’Ivoire

View Trial Details

Active, Not Recruiting

A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection

NCT07183306

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Beijing Ditan Hospital Capital Medical University Beijing, Beijing Municipality, China

Xiamen Hospital of Traditional Chinese Medicine Xiamen, Fujian, China

Guangzhou Eighth People's Hospital, Guangzhou Medical University Guangzhou, Guangdong, China

Nanfang Hospital Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)

NCT04863703

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +16 more
Locations: Hannover Medical School Hanover, Lower Saxony, Germany

View Trial Details

Active, Not Recruiting

India HIV-CervCa Project

NCT07167069

Conditions: Blood-Borne Infections, Cervical Cancer, Communicable Diseases, +26 more
Locations: Tata Memorial Hospital Mumbai, Maharashtra, India

View Trial Details

Active, Not Recruiting

Community Intervention to Eliminate HCV Among People Who Use Drugs.

NCT05794646

Conditions: Behavior, Blood-Borne Infections, Chemically-Induced Disorders, +16 more
Locations: Lyon Lyon, Auvergne-Rhône-Alpes, France

Marseille Marseille, PACA, France

Paris Paris, Île-de-France Region, France

Martinique Fort-de-France, Martinique

View Trial Details

Active, Not Recruiting

Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients

NCT05970289

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations: Investigative Site 61001 Kingswood, New South Wales, Australia

Investigative Site 61002 Birtinya, Queensland, Australia

Investigative Site 61003 Melbourne, Victoria, Australia

Investigative Site 86001 Beijing, Beijing Municipality, China

View all 29 locations

View Trial Details

Blood-Borne Infections

Blood-Borne Infections trial results

Related conditions